Analyst Signal

Merck & Company, Inc. (MRK) is currently trading at $120.87. Based on 27 Wall Street analysts, the average target price is $128.26, implying a 6.1% upside. The consensus recommendation is BUY.

MRK

Merck & Company, Inc.

HealthcareOpinion: buy

Opinion Criteria: Based on the consensus of Wall Street analysts. Strong Buy (1.0-1.5), Buy (1.5-2.5), Hold (2.5-3.5), Sell (3.5-4.5), Strong Sell (4.5-5.0).

Price (USD)

$120.87

Avg Target

$128.26

Based on 27 analysts

Analyst Recommendations

Buy (18)Hold (11)Sell (0)

Upside

+6.11%

Market Cap

$298.84B

Financial & Investment Metrics

Next Earnings Date
Apr 30, 2026D-27
P/E Ratio (TTM)16.63
Forward P/E12.41
P/B Ratio5.69
Dividend Yield2.81%
Return on Equity (ROE)36.88%
Operating Margin32.77%
Debt to Equity95.96
Beta (Volatility)0.26
52 Week Range$73.31 - $125.14
LowCurrent: $120.87High

Insider Sentiment Index (Last 6 Months)

Buy vs Sell (Count)

Insider Buys: 16Insider Sells: 14

Whale Trades (C-Level Large Buys)

No major insider buying detected recently.

Recent Insider Transactions

DateNamePositionTransactionShares
2/12/2026GUINDO CHIRFIOfficerSale at price 121.46 per share.10,000
2/10/2026LI DEAN YOfficerSale at price 117.52 per share.10,235
2/9/2026ZACHARY JENNIFER LGeneral CounselSale at price 119.15 per share.121,573
2/9/2026GUINDO CHIRFIOfficerSale at price 118.41 per share.10,000
2/9/2026ZACHARY JENNIFER LGeneral CounselConversion of Exercise of derivative security at price 119.15 per share.121,573
2/6/2026WILLIAMS DAVID MICHAELChief Technology OfficerSale at price 121.90 per share.5,000
2/6/2026DELUCA RICHARD ROBERT JR.OfficerSale at price 120.92 per share.37,685
2/6/2026OOSTHUIZEN JOHANNES JACOBUSOfficerSale at price 121.87 per share.15,000
2/6/2026WILLIAMS DAVID MICHAELChief Technology OfficerConversion of Exercise of derivative security at price 77.62 per share.5,000
2/5/2026GUINDO CHIRFIOfficerSale at price 121.88 per share.20,000

Frequently Asked Questions

Q. What is the current target price and upside for MRK?

A. The current target price for Merck & Company, Inc. is $128.26, which implies a 6.1% upside from the current price of $120.87. This is based on the consensus of 27 Wall Street analysts.

Q. What is the current analyst recommendation for MRK?

A. Currently, there are 4 Strong Buy, 14 Buy, 11 Hold, 0 Sell, and 0 Strong Sell ratings. The overall consensus is BUY.

Q. Are insiders buying MRK stock recently?

A. Over the past 6 months, there have been 16 insider buys and 14 insider sells. This can be interpreted as a positive signal.

Other Promising Stocks in Healthcare

MRK (Merck & Company, Inc.) Stock Analysis | Analyst Signal